Title : IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C.

Pub. Date : 2017 Mar

PMID : 27027531






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C. AIM: Older patients with chronic hepatitis C have a lower virological response to interferon (IFN)-based treatments compared to younger patients. Ribavirin interferon lambda 4 (gene/pseudogene) Homo sapiens